Erratum: Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression (Small GTPase RBJ Mediates Nuclear Entrapment of MEK1/MEK2 in Tumor Progression (2014) 25(5) (682–696), (S1535610814001184), (10.1016/j.ccr.2014.03.009));Small GTPase RBJ mediates nuclear entrapment of MEK1/MEK2 in tumor progression

Cancer Cell

Volumn 25, Issue 5, 2014, Pages 682-696

  Chen, Taoyong ^a,b   Yang, Mingjin ^a,b   Yu, Zhou ^c   Tang, Songqing ^c   Wang, Chen ^a   Zhu, Xuhui ^a   Guo, Jun ^a,f   Li, Nan ^a   Zhang, Weiping ^a   Hou, Jin ^a   Liu, Haibo ^a   Han, Chaofeng ^a   Liu, Qiuyan ^a   Gu, Yan ^a   Qian, Cheng ^a   Wan, Tao ^a   Cui, Long ^d   Zhu, Minghua ^e   Zheng, Weiqiang ^e   Cao, Xuetao ^a,b,c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; SMALL GUANOSINE TRIPHOSPHATASE RBJ; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; COLON CARCINOGENESIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR GROWTH;

3T3 CELLS; ANIMALS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION; GTP PHOSPHOHYDROLASES; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, NUDE; MOLECULAR SEQUENCE DATA; RAB GTP-BINDING PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84900332889     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2021.02.010     Document Type: Erratum

References (48)

1. Aaronson S.A., Todaro G.J. Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J.Cell. Physiol. 1968, 72:141-148.
2. Adachi M., Fukuda M., Nishida E. Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J.Cell Biol. 2000, 148:849-856.
3. Bollag G., Hirth P., Tsai J., Zhang J., Ibrahim P.N., Cho H., Spevak W., Zhang C., Zhang Y., Habets G., et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 2010, 467:596-599.
4. Burack W.R., Shaw A.S. Live cell imaging of ERK and MEK: simple binding equilibrium explains the regulated nucleocytoplasmic distribution of ERK. J.Biol. Chem. 2005, 280:3832-3837.
5. Chen T., Han Y., Yang M., Zhang W., Li N., Wan T., Guo J., Cao X. Rab39, a novel Golgi-associated Rab GTPase from human dendritic cells involved in cellular endocytosis. Biochem. Biophys. Res. Commun. 2003, 303:1114-1120.
6. Chen X., Leung S.Y., Yuen S.T., Chu K.M., Ji J., Li R., Chan A.S., Law S., Troyanskaya O.G., Wong J., et al. Variation in gene expression patterns in human gastric cancers. Mol. Biol. Cell 2003, 14:3208-3215.
7. Cowley S., Paterson H., Kemp P., Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994, 77:841-852.
8. D'Errico M., de Rinaldis E., Blasi M.F., Viti V., Falchetti M., Calcagnile A., Sera F., Saieva C., Ottini L., Palli D., et al. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. Eur. J. Cancer 2009, 45:461-469.
9. dos Santos G.R., Nepomuceno-Silva J.L., de Melo L.D., Meyer-Fernandes J.R., Salmon D., Azevedo-Pereira R.L., Lopes U.G. The GTPase TcRjl of the human pathogen Trypanosoma cruzi is involved in the cell growth and differentiation. Biochem. Biophys. Res. Commun. 2012, 419:38-42.
10. Duhamel S., Hébert J., Gaboury L., Bouchard A., Simon R., Sauter G., Basik M., Meloche S. Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation. Cancer Res. 2012, 72:626-635.
11. Elias M., Archibald J.M. The RJL family of small GTPases is an ancient eukaryotic invention probably functionally associated with the flagellar apparatus. Gene 2009, 442:63-72.
12. Esteller M. Epigenetics in cancer. N.Engl. J. Med. 2008, 358:1148-1159.
13. Friday B.B., Adjei A.A. K-ras as a target for cancer therapy. Biochim. Biophys. Acta 2005, 1756:127-144.
14. Fukuda M., Gotoh I., Gotoh Y., Nishida E. Cytoplasmic localization of mitogen-activated protein kinase kinase directed by its NH2-terminal, leucine-rich short amino acid sequence, which acts as a nuclear export signal. J.Biol. Chem. 1996, 271:20024-20028.
15. Fukuda M., Gotoh I., Adachi M., Gotoh Y., Nishida E. A novel regulatory mechanism in the mitogen-activated protein (MAP) kinase cascade. Role of nuclear export signal of MAP kinase kinase. J.Biol. Chem. 1997, 272:32642-32648.
16. Fukuda M., Gotoh Y., Nishida E. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J. 1997, 16:1901-1908.
17. Gaspar C., Cardoso J., Franken P., Molenaar L., Morreau H., Möslein G., Sampson J., Boer J.M., de Menezes R.X., Fodde R. Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am. J. Pathol. 2008, 172:1363-1380.
18. Gotoh I., Fukuda M., Adachi M., Nishida E. Control of the cell morphology and the S phase entry by mitogen-activated protein kinase kinase. A regulatory role of its n-terminal region. J.Biol. Chem. 1999, 274:11874-11880.
19. Han C., Chen T., Li N., Yang M., Wan T., Cao X. HDJC9, a novel human type C DnaJ/HSP40 member interacts with and cochaperones HSP70 through the J domain. Biochem. Biophys. Res. Commun. 2007, 353:280-285.
20. Hancock J.F., Paterson H., Marshall C.J. A polybasic domain or palmitoylation is required in addition to the CAAX motif to localize p21ras to the plasma membrane. Cell 1990, 63:133-139.
21. Hansen G.M., Markesich D.C., Burnett M.B., Zhu Q., Dionne K.M., Richter L.J., Finnell R.H., Sands A.T., Zambrowicz B.P., Abuin A. Large-scale gene trapping in C57BL/6N mouse embryonic stem cells. Genome Res. 2008, 18:1670-1679.
22. Hong Y., Downey T., Eu K.W., Koh P.K., Cheah P.Y. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin. Exp. Metastasis 2010, 27:83-90.
23. Jaaro H., Rubinfeld H., Hanoch T., Seger R. Nuclear translocation of mitogen-activated protein kinase kinase (MEK1) in response to mitogenic stimulation. Proc. Natl. Acad. Sci. USA 1997, 94:3742-3747.
24. Jameson K.L., Mazur P.K., Zehnder A.M., Zhang J., Zarnegar B., Sage J., Khavari P.A. IQGAP1 scaffold-kinase interaction blockade selectively targets RAS-MAP kinase-driven tumors. Nat. Med. 2013, 19:626-630.
25. Johnson L., Mercer K., Greenbaum D., Bronson R.T., Crowley D., Tuveson D.A., Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001, 410:1111-1116.
26. Jorissen R.N., Gibbs P., Christie M., Prakash S., Lipton L., Desai J., Kerr D., Aaltonen L.A., Arango D., Kruhøffer M., et al. Metastasis-associated gene expression changes predict poor outcomes in patients with Dukes stage B and C colorectal cancer. Clin. Cancer Res. 2009, 15:7642-7651.
27. Kaiser S., Park Y.K., Franklin J.L., Halberg R.B., Yu M., Jessen W.J., Freudenberg J., Chen X., Haigis K., Jegga A.G., et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 2007, 8:R131.
28. Karnoub A.E., Weinberg R.A. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 2008, 9:517-531.
29. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 2005, 6:827-837.
30. Lee S.H., Lee J.W., Soung Y.H., Kim S.Y., Nam S.W., Park W.S., Kim S.H., Yoo N.J., Lee J.Y. Colorectal tumors frequently express phosphorylated mitogen-activated protein kinase. APMIS 2004, 112:233-238.
31. Luke J.J., Hodi F.S. Vemurafenib and BRAF inhibition: a new class of treatment for metastatic melanoma. Clin. Cancer Res. 2012, 18:9-14.
32. Mansour S.J., Matten W.T., Hermann A.S., Candia J.M., Rong S., Fukasawa K., Vande Woude G.F., Ahn N.G. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994, 265:966-970.
33. Nepomuceno-Silva J.L., de Melo L.D., Mendonçã S.M., Paixão J.C., Lopes U.G. RJLs: a new family of Ras-related GTP-binding proteins. Gene 2004, 327:221-232.
34. Neufert C., Becker C., Neurath M.F. An inducible mouse model ofcolon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc. 2007, 2:1998-2004.
35. Poulikakos P.I., Zhang C., Bollag G., Shokat K.M., Rosen N. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF. Nature 2010, 464:427-430.
36. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Varambally R., Yu J., Briggs B.B., Barrette T.R., Anstet M.J., Kincead-Beal C., Kulkarni P., et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 2007, 9:166-180.
37. Roy M., Li Z., Sacks D.B. IQGAP1 binds ERK2 and modulates its activity. J.Biol. Chem. 2004, 279:17329-17337.
38. Sabates-Bellver J., Van der Flier L.G., de Palo M., Cattaneo E., Maake C., Rehrauer H., Laczko E., Kurowski M.A., Bujnicki J.M., Menigatti M., et al. Transcriptome profile of human colorectal adenomas. Mol. Cancer Res. 2007, 5:1263-1275.
39. Sebolt-Leopold J.S., Dudley D.T., Herrera R., Van Becelaere K., Wiland A., Gowan R.C., Tecle H., Barrett S.D., Bridges A., Przybranowski S., et al. Blockade of the MAP kinase pathway suppresses growth of colon tumors invivo. Nat. Med. 1999, 5:810-816.
40. Skrzypczak M., Goryca K., Rubel T., Paziewska A., Mikula M., Jarosz D., Pachlewski J., Oledzki J., Ostrowski J. Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. PLoS One 2010, 5:e13091.
41. Takeno A., Takemasa I., Seno S., Yamasaki M., Motoori M., Miyata H., Nakajima K., Takiguchi S., Fujiwara Y., Nishida T., et al. Gene expression profile prospectively predicts peritoneal relapse after curative surgery of gastric cancer. Ann. Surg. Oncol. 2010, 17:1033-1042.
42. Therrien M., Michaud N.R., Rubin G.M., Morrison D.K. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 1996, 10:2684-2695.
43. Tolwinski N.S., Shapiro P.S., Goueli S., Ahn N.G. Nuclear localization of mitogen-activated protein kinase kinase 1 (MKK1) is promoted by serum stimulation and G2-M progression. Requirement for phosphorylation at the activation lip and signaling downstream of MKK. J.Biol. Chem. 1999, 274:6168-6174.
44. Torii S., Kusakabe M., Yamamoto T., Maekawa M., Nishida E. Sef is a spatial regulator for Ras/MAP kinase signaling. Dev. Cell 2004, 7:33-44.
45. Trunzer K., Pavlick A.C., Schuchter L., Gonzalez R., McArthur G.A., Hutson T.E., Moschos S.J., Flaherty K.T., Kim K.B., Weber J.S., et al. Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma. J.Clin. Oncol. 2013, 31:1767-1774.
46. Wang C., Chen T., Zhang J., Yang M., Li N., Xu X., Cao X. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat. Immunol. 2009, 10:744-752.
47. Wright J.H., Munar E., Jameson D.R., Andreassen P.R., Margolis R.L., Seger R., Krebs E.G. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. USA 1999, 96:11335-11340.
48. Yao Z., Flash I., Raviv Z., Yung Y., Asscher Y., Pleban S., Seger R. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1. Oncogene 2001, 20:7588-7596.